Keith G. Rasmussen, MD
- 5Articles
- 12.5KReads
- 2007–2019Active
- 19Collaborators
- 544Citations
About
Keith G. Rasmussen, MD, has published extensively on major depressive disorder, focusing on treatment-resistant depression and electroconvulsive therapy (ECT). His work includes analyses of factors influencing remission rates following ECT and intravenous ketamine, as well as investigations into medication resistance and genetic markers related to ECT outcomes. Rasmussen's research spans neurology and psychopharmacology, contributing to understanding clinical predictors and treatment responses in depression.
Publications
BMI and Remission in Depressed Patients Receiving IV Ketamine
November 12, 2019
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
